Peg S O'rourke, PH.D. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 610 N 4th St, Suite 110a, Burlington, IA 52601 Phone: 319-754-8035 Fax: 319-754-9213 |
Theresa Reckling, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 205 Washington St Ste 200, Burlington, IA 52601 Phone: 319-208-1280 |
Candi Francis, TLMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 205 Washington St, Suite 200, Burlington, IA 52601 Phone: 319-208-1280 |
Ms. Mona Riley Smith, M.F.T. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 610 N 4th St, #125, Burlington, IA 52601 Phone: 319-752-5295 Fax: 319-752-5295 |
Scott E Bair, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1621 Dodge St, Burlington, IA 52601 Phone: 319-457-2282 Fax: 319-865-3110 |
News Archive
A new study sheds light on the prevalence of insomnia symptoms among female veterans. Results demonstrate that more than 47 percent of female veterans reported symptoms of insomnia that resulted in functional impairment. Of this sample group, less than one percent had a diagnosis of a sleep disorder based on medical records.
For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.
Cancer is an unwanted experiment in progress. As the disease advances, tumor cells accumulate mutations, eventually arriving at ones that give them the insidious power to grow uncontrollably and spread. Distinguishing drivers of cancer from benign mutations open opportunities for developing targeted cancer therapies.
Mount Sinai researchers have developed machine learning models that predict the likelihood of critical events and mortality in COVID-19 patients within clinically relevant time windows.
Boehringer Ingelheim and Eli Lilly and Company today announced that the U.S. Food and Drug Administration has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.
› Verified 9 days ago